Alireza Moshaverinia, a USC dental researcher, recently received the 2015 IADR Innovation in Oral Care Award for his groundbreaking research into the treatment of peri-implantitis, a common, destructive inflammatory complication in dental implant patients. As many as two in five implant patients experience peri-implantitis and related bone and tissue loss. Moshaverinia developed an injectable adhesive hydrogel which included mesenchymal stem cells and anti-inflammatory/antimicrobial properties.
In addition to promising clinical effects in the treatment of inflammation, the hydrogel promotes the growth of tissue and new bone, potentially limiting the role (and risks) of surgery. “The long-term goal . . . is to introduce a promising approach for the improved treatment of peri-implant bone loss and to extend it to the repair of maxillofacial and skeletal defects paving the way for improved hard tissue regeneration in the clinics,” Moshaverinia said.
This innovative development holds promise because it offers a less invasive solution to a chronic problem. Dr. Moshaverinia’s research is an example of the potential for stem cell regenerative medical therapies to effectively treat seemingly intractable and incurable conditions. To learn more about stem cells and how to insure immediate access to emerging personalized regenerative treatments by banking your own valuable stem cells, please visit StemSave or call 877-783-6728 (877- StemSave) today.
To view the full article, click here.
The Future of Regenerative Medicine is Now™.